Development of chitosan-based dry powder inhalation system of cisplatin for lung cancer

Indian Journal of Pharmaceutical Sciences

Volumn 74, Issue 6, 2012, Pages 521-526

  Singh, D J ^a   Lohade, A A ^a   Parmar, J J ^a   Hegde, Darshana D ^a   Soni, P ^b   Samad, A ^c   Menon, Mala D ^a  

^a BOMBAY COLLEGE OF PHARMACY   (India)

^b Board of Radiation and Isotope Technology and Medical Cyclotron Facility   (India)

^c BOMBAY VETERINARY COLLEGE   (India)

Author keywords

Cisplatin; dry powder inhalation; microspheres; pulmonary delivery

Indexed keywords

CHITOSAN; CISPLATIN; MICROSPHERE;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRY POWDER; EMULSION; GAS CHROMATOGRAPHY; IN VITRO STUDY; LUNG CANCER; LUNG FLUID; MOISTURE; PARTICLE SIZE; PH; SCANNING ELECTRON MICROSCOPY;

EID: 84876935277     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.110584     Document Type: Article

References (21)

1. Courrier HM, Butz N, Vandamme TF. Pulmonary drug delivery systems: Recent developments and prospects. Crit Rev Ther Drug Carrier Syst 2002;19:425-98.
2. Groneberg DA, Witt C, Wagner U, Chung KF, Fischer A. Fundamentals of pulmonary drug delivery. Respir Med 2003;97:382-7.
3. Zeng XM, Martin GP, Marriott C. The controlled delivery of drugs to the lung. Int J Pharm 1995;124:149-64.
4. Witek TJ. The Fate of Inhaled Drugs: The pharmacokinetics and pharmacodynamics of drugs administered by aerosol. Respir Care 2000;45:826-30.
5. Clark AR. Pulmonary Delivery Technology: Recent Advances and Potential for the New Millennium. In: Hickey AJ, editor. Pharmaceutical Inhalation Aerosol Technology. 2nd ed. New York: Marcel Dekker Inc.; 2004. p. 563-84.
6. Byron PR. Prediction of drug residence times in regions of the human respiratory tract following aerosol inhalation. J Pharm Sci 1986;75:433-8.
7. Shenfield GM, Evans ME, Paterson JW. Absorption of drugs by the lung. Br J Clin Pharm 1976;3:1218-23.
8. Adjei A, Gupta P. Dry-powder inhalation aerosols. In: Adjei AL, Gupta PK, editors, Inhalation Delivery of Therapeutic Peptides and Proteins. New York: Marcel Dekker; 1997. p. 625-65.
9. Clegg A, Scott D, Hewitson P. Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbinein non small cell lung cancer: A systematic review. Thorax 2002;57:20-8.
10. Pieter P, Stephen J. Cisplatin and related drugs. In: Bertino JR editor, Encyclopedia of cancer. New York: Academic Press; 1996. p. 392-410.
11. Davies NM, Feddah MR, A novel method for assessing dissolution of aerosol inhaler products. Int J Pharm 2003;255:175-87
12. Martinac A, Filipovic-Grcic J, Voinovich D, Perissutti B, Franceschinis E. Development and bioadhesive properties of chitosan-ethylcellulose microspheres for nasal delivery. Int J Pharm 2005;291:69-77.
13. Mi F, Wong T, Shyu S, Chang S. Chitosan microspheres: Modification of polymeric anti-physical properties of spray dried microspheres to control the release of antibiotic drug. J Appl Polym Sci 1999;71:747-59.
14. Berthold K, Cremer J, Kreuter J. Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for antiinflammatory drugs. Control Release 1996;39:17-25.
15. Anal A, Willem F, Carmen R. Ionotropic cross-linked chitosan microspheres for controlled release of ampicillin. Int J Pharm 2006;312:166-73.
16. Lim L, Wan L, Thai P. Chitosan microspheres prepared by emulsification and ionotropic gelation. Drug Dev Ind Pharm 1997;23:981-5.
17. Nishioka Y, Kyotani S, Okamura M, Miyazaki M, Okazaki K, Ohnishi S et al. Release characteristics of cisplatin chitosan microspheres and effect of containing chitin. Chem Pharm Bull 1990;38:2871-3.
18. Staniforth J. Improvement in dry powder inhaler performance: Surface passivation effects. Proc Drug Deliv Lungs (London) 1996;7:86-9.
19. Lucas P, Anderson K, Potter U, Staniforth J. Enhancement of small particle size dry powder aerosol formulations using an ultra low density additive. Pharm Res 1999;16:1643-7.
20. Louey M, Razia S, Stewart P. Influence of physicochemical carrier properties on the in vitro aerosol deposition from interactive mixtures. Int J Pharm 2003;252:87-98.
21. Liang CH, Liu LF, Shiu LY, Huang YS, Chang LC, Kuo KW. Action of solamargine on TNFs and cisplatin resistant human lung cancer calls. Biochem Biophys Res Commun 2004;322:751-8.